MENU
+Compare
MEIP
Stock ticker: NASDAQ
AS OF
May 30 closing price
Price
$2.24
Change
+$0.05 (+2.28%)
Capitalization
14.92M

MEIP MEI Pharma Forecast, Technical & Fundamental Analysis

MEI Pharma Inc is focused on the clinical development of novel therapies for cancer... Show more

MEIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for MEIP with price predictions
May 30, 2025

MEIP in upward trend: 10-day moving average broke above 50-day moving average on May 22, 2025

The 10-day moving average for MEIP crossed bullishly above the 50-day moving average on May 22, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on May 30, 2025. You may want to consider a long position or call options on MEIP as a result. In of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

MEIP moved above its 50-day moving average on May 29, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MEIP advanced for three days, in of 238 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 95 cases where MEIP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MEIP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MEIP broke above its upper Bollinger Band on May 14, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.764) is normal, around the industry mean (16.282). P/E Ratio (1.094) is within average values for comparable stocks, (59.596). MEIP's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.224). Dividend Yield (0.000) settles around the average of (0.039) among similar stocks. P/S Ratio (0.298) is also within normal values, averaging (269.262).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MEIP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MEIP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
MEIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

MEIP is expected to report earnings to fall 94.31% to -13 cents per share on August 31

MEI Pharma MEIP Stock Earnings Reports
Q2'23
Est.
$-0.13
Q1'23
Beat
by $0.55
Q4'22
Beat
by $0.22
Q3'22
Beat
by $0.05
Q2'22
Missed
by $0.02
The last earnings report on May 11 showed earnings per share of -231 cents, beating the estimate of -286 cents. With 1.72K shares outstanding, the current market capitalization sits at 14.92M.
A.I. Advisor
published General Information

General Information

a mfactures pharmaceuticals products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
11455 El Camino Real
Phone
+1 858 369-7100
Employees
102
Web
https://www.meipharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WKSP2.870.04
+1.27%
Worksport Ltd
PPL34.750.33
+0.96%
PPL Corp
WRLD155.63-0.58
-0.37%
World Acceptance Corp
TCX19.50-0.11
-0.56%
Tucows
BXMT18.89-0.21
-1.10%
Blackstone Mortgage Trust

MEIP and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MEIP has been loosely correlated with GOSS. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if MEIP jumps, then GOSS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MEIP
1D Price
Change %
MEIP100%
+2.28%
GOSS - MEIP
45%
Loosely correlated
-1.33%
DNLI - MEIP
30%
Poorly correlated
-2.22%
AXON - MEIP
28%
Poorly correlated
+2.68%
SAGE - MEIP
27%
Poorly correlated
-1.07%
GLUE - MEIP
26%
Poorly correlated
-0.71%
More